Hyperhomocysteinemia: A risk factor for placental abruption or infarction

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 66, Issue 1, 1996, Pages 23-29

  Goddijn Wessel, Toos A W ^a   Wouters, Maurice G A J ^a   Molen, Els F ^a   Spuijbroek, Marleen D E H ^a   Steegers Theunissen, Régine P M ^a   Blom, Henk J ^a   Boers, Godfried H J ^a   Eskes, Tom K A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Folate; Homocysteine; Placental abruption infarction; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; METHIONINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; PREGNANCY DISORDER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SOLUTIO PLACENTAE;

EID: 0029935556     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/0301-2115(96)02383-4     Document Type: Article

References (32)

1. Mudd SH, Levy HL. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989; 693-734.
2. Rosenblatt DS. Inherited disorders of folate transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989; 2049-2064.
3. Fenton WA, Rosenberg LE. Inherited disorders of cobalamin transport and metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic basis of inherited diseases. New York: McGraw-Hill, 1989; 2065-2082.
4. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985; 37: 1-31.
5. Boers GHJ, Fowler B, Smals AGH, Trijbels FJM, Leermakers AI, Kleijer WJ, Kloppenburg PWC. Improved identification of heterozygotes for homocystinuria due to cystathionine synthase deficiency by the combination of methionine loading and enzyme determination in cultured fibroblasts. Hum Genet 1985; 69: 164-169.
6. Clarke R, Daly L, Robinson K, Naugthen E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991; 324: 1149-1155.
7. Kang SS, Wong PWK, Susmano A, Sora J, Norusis M, Ruggie N. Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease. Am J Hum Genet 1991; 48: 536-545.
8. Engbersen AMT, Franken DG, Boers GHJ, Stevens EMB, Trijbels FJM, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 1995; 56: 142-150.
9. Ueland PM, Refsum H, Brattström L. Plasma homocysteine and cardiovascular disease. In: Francis RB, editor. Atherosclerotic cardiovascular disease, hemostasis, and endothelial function. New York: Marcel Dekker, 1992: 183-236.
10. Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992; 12: 279-298.
11. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. J Am Med Assoc 1992; 268: 877-881.
12. Steegers-Theunissen RPM, Boers GHJ, Blom HJ, Trijbels JMF, Eskes TKAB. Hyperhomocysteinemia and recurrent abortion or abruptio placentae [letter]. Lancet 1992; 339: 1122-1123.
13. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels JMF, Thomas CMG, Borm GF, Steegers-Theunissen RPM, Eskes TKAB. Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993; 60: 120-125.
14. Ueland PM, Refsum H, Stabler SP, Malinow R, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem 1994; 39: 1764-1779.
15. Fiskerstrand T, Refsum H, Kvalheim G, Ueland PM. Homocysteine and other thiols determined in plasma and urine: automation and sample stability. Clin Chem 1993; 39: 263-271.
16. Te Poele-Pothoff MTWB, Van den Berg M, Franken DG, Boers GHJ, Jakobs C, De Kroon IFI, Eskes TKAB, Trijbels JMF, Blom HJ. Three different methods for determination of total homocysteine in plasma. Ann Clin Biochem 1995; 32: 218-220.
17. Mooij PNM, Thomas CMG, Doesburg WH, Eskes TKAB. Multivitamin supplementation in oral contraceptive users. Contraception 1991; 44: 277-288.
18. Steegers-Theunissen RPM, Boers GHJ, Steegers EAP, Trijbels JMF, Thomas CMG, Eskes TKAB. Effects of sub-50 oral contraceptives on homocysteine metabolism. Contraception 1992; 45: 129-139.
19. Macpherson T. Fact and fancy: what can we really tell from the placenta. Arch Pathol Lab Med 1991; 115: 672-681.
20. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991; 98: 648-655.
21. Domisse J, Tiltman AJ. Placental bed biopsies in placental abruption. Br J Obstet Gynaecol 1992; 99: 651-654.
22. Kaplan C. Placental pathology for the nineties. Pathol Annu 1993; 28: 15-72.
23. Rayne SC, Kraus FT. Placental thrombi and other vascular lesions. Classification, morphology, and clinical correlations. Pathol Res Pract 1993; 189: 2-17.
24. Hilden M, Brandt NJ, Schonheyder F, Quaade F. Homocystinuri. Et tilfaelde. Ugeskrift for laeger 1972; 134: 498-502.
25. Finkelstein JD. Methionine metabolism in mammals. J Nutr 1990; 1: 228-237.
26. Van de Molen EF, Van de Heuvel LPWJ, Monnens LAH, Eskes TKAB, Blom HJ. The effect of folic acid on the methionine/ homocysteine metabolism in human umbilical venous endothelial cells (HUVEC). Eur J Clin Invest. In press.
27. Hibbard BM. The role of folic acid in pregnancy - with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Commonw 1964; 71: 529-542.
28. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GHJ, Den Heyer M, Kluijtmans LAJ, Van den Heuvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase locus. Nat Genet 1995; 10: 111-113.
29. Brattström L, Israelsson B, Norrving B, Bergqvist D, Thörne J, Hultberg B, Hamfelt A. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease - effects of pyridoxine and folic acid treatment. Atherosclerosis 1990; 81: 51-60.
30. Dudman NPB, Wilcken DEL, Wang J, Lynch JF, Macey D, Lundberg P. Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology. Arterioscler Thromb 1993; 13: 1253-1260.
31. Franken DG, Boers GHJ, Blom HJ, Trijbels JMF, Kloppenborg PWC. Treatment of mild hyperhomocysteinemia in vascular patients. Arterioscler Thromb 1994; 14: 1465-1470.
32. Van den Berg M, Franken DG, Boers GHJ, Blom HJ, Jakobs C, Stehouwer CDA, Rauwerda JA. Combined vitamin B6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. J Vase Surg 1994; 20: 933-940.